Home/Filings/4/0001596180-14-000007
4//SEC Filing

IMPLANT SCIENCES CORP 4

Accession 0001596180-14-000007

CIK 0001068874operating

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 5:07 PM ET

Size

5.5 KB

Accession

0001596180-14-000007

Insider Transaction Report

Form 4
Period: 2014-03-06
McGann William J
DirectorChief Operating Officer
Transactions
  • Award

    Stock Option(Right to Buy)

    2014-03-06+75,00075,000 total
    Exercise: $0.79Exp: 2014-03-05Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in full upon the later of (i) the addition of the Issuer's QS-B220 product to the Transportation Security Administration (TSA) Qualified Product List for passenger checkpoint screening and (ii) the Issuer's receipt of an initial order for such products under an indefinite delivery/indefinite quantity contact with the TSA.

Issuer

IMPLANT SCIENCES CORP

CIK 0001068874

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0001068874

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 5:07 PM ET
Size
5.5 KB